DiaMedica Therapeutics Inc. (DMAC)
NASDAQ: DMAC · Real-Time Price · USD
3.760
+0.190 (5.32%)
At close: Jul 3, 2025, 1:00 PM
3.740
-0.020 (-0.53%)
After-hours: Jul 3, 2025, 4:46 PM EDT
DiaMedica Therapeutics Market Cap
DiaMedica Therapeutics has a market cap or net worth of $161.24 million as of July 3, 2025. Its market cap has increased by 77.77% in one year.
Market Cap
161.24M
Enterprise Value
124.24M
1-Year Change
77.77%
Ranking
Category
Stock Price
$3.76
Market Cap Chart
Since December 7, 2018, DiaMedica Therapeutics's market cap has increased from $36.70M to $161.24M, an increase of 339.35%. That is a compound annual growth rate of 25.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2025 | 161.20M | -30.58% |
| Dec 31, 2024 | 232.20M | 115.40% |
| Dec 29, 2023 | 107.80M | 157.89% |
| Dec 30, 2022 | 41.80M | -57.61% |
| Dec 31, 2021 | 98.60M | -48.11% |
| Dec 31, 2020 | 190.00M | 226.46% |
| Dec 31, 2019 | 58.20M | 68.70% |
| Dec 31, 2018 | 34.50M | -5.99% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 697.44B |
| Johnson & Johnson | 375.32B |
| AbbVie | 334.87B |
| Novo Nordisk | 309.43B |
| UnitedHealth Group | 281.39B |
| Novartis AG | 243.28B |
| Abbott Laboratories | 232.89B |
| AstraZeneca | 219.33B |